Academic literature on the topic 'Stadiazione'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Stadiazione.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Stadiazione"
Roncallo, F., I. Turtulici, L. Giberti, and A. Bartolini. "Stadiazione e controllo dei carcinomi del rinofaringe." Rivista di Neuroradiologia 10, no. 2_suppl (October 1997): 169–72. http://dx.doi.org/10.1177/19714009970100s272.
Full textAnselmo, G., E. Felici, E. Bassi, L. Maccatrozzo, F. Merlo, and A. Fandella. "Stadiazione/Risultati Nella Prostatectomia Radicale per Cancro." Urologia Journal 55, no. 3 (June 1988): 268–72. http://dx.doi.org/10.1177/039156038805500307.
Full textSpinelli, Pasquale, Marcello Schiavo, and Angelo Aldo Schicchi. "L'endoscopia Nella Diagnosi E Stadiazione Del Carcinoma Pancreatico." Tumori Journal 85, no. 1_suppl (January 1999): 14–18. http://dx.doi.org/10.1177/030089169908501s05.
Full textMedica, M., C. Borzone, C. Frola, M. Pacella, M. De Paolis, and G. P. Bruttini. "La Risonanza Magnetica Nucleare Nella Stadiazione Del Carcinoma Della Vescica." Urologia Journal 56, no. 3 (June 1989): 359–64. http://dx.doi.org/10.1177/039156038905600318.
Full textGherardi, L., A. Tamai, D. Xausa, P. Silvestre, A. Giunta, and G. Breda. "Valore Della Diagnostica per Immagini Nella Stadiazione Del Carcinoma Prostatico." Urologia Journal 57, no. 1 (February 1990): 88–95. http://dx.doi.org/10.1177/039156039005700117.
Full textPianon, C., S. Melotti, G. Viggiano, A. Nasta, G. Zanocco, A. Bucci, and R. Dal Poz. "Confronto Tra Stadiazione Ecografica E Anatomopatologica Nei Pazienti Sottoposti a Prostatectomia Radicale." Urologia Journal 57, no. 6 (December 1990): 619–20. http://dx.doi.org/10.1177/039156039005700609.
Full textRoncallo, F., I. Turtulici, A. Bartolini, G. Margarino, P. Mereu, F. Scasso, L. Scotto Di Santillo, A. Santelli, G. Garaventa, and A. Tedeschi. "Tomografia computerizzata e risonanza magnetica nella patologia del distretto testa-collo." Rivista di Neuroradiologia 9, no. 3 (June 1996): 301–20. http://dx.doi.org/10.1177/197140099600900306.
Full textMonica, B., A. Frattini, A. Prati, I. Pieri, and D. Potenzoni. "Affidabilità Della Tc Nella Stadiazione Delle Neoplasie Vescicali: Considerazioni Su 45 Casi Operati." Urologia Journal 56, no. 4 (August 1989): 500–503. http://dx.doi.org/10.1177/039156038905600418.
Full textTriulzi, F., and G. Scotti. "La RM nella patologia sellare e parasellare." Rivista di Neuroradiologia 1, no. 1_suppl (April 1988): 75–93. http://dx.doi.org/10.1177/19714009880010s109.
Full textZattoni, F., F. Vianello, L. D'Arrigo, T. Prayer Galetti, F. Dal Moro, and F. Pagano. "Predittività della stadiazione clinica nel carcinoma clinicamente localizzato: Clinical staging accuracy in clinically localised carcinoma." Urologia Journal 62, no. 1 (February 1995): 32–34. http://dx.doi.org/10.1177/039156039506200106.
Full textDissertations / Theses on the topic "Stadiazione"
RAMIREZ, CAROLINA. "VALUTAZIONE DEI PARAMETRI ERITROCITARI E RETICOLOCITARI NEL PAZIENTE FELINO NEFROPATICO IN RELAZIONE ALLA STADIAZIONE IRIS." Doctoral thesis, Università degli Studi di Milano, 2009. http://hdl.handle.net/2434/201313.
Full textLaterza, Liboria <1981>. "L'Ecoendoscopia nella stadiazione locale dei tumori neuroendocrini del tratto digestivo suscettibili di resezione endoscopica: l'esperienza di un centro." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2016. http://amsdottorato.unibo.it/7390/1/Laterza_Liboria_tesi.pdf.
Full textBackground and aim: Diagnostic role of endoscopic ultrasound (EUS) in gastrointestinal neuroendocrine tumors (GE-NETs) is the local staging based on the assessment of wall depth (T) and of lymph nodes metastasis (N). Diagnostic accuracy of EUS in T-staging is 94-100%. Endoscopic resection is a treatment option in selected cases. Aim of the current study was to evaluate diagnostic accuracy of EUS in the local staging of GE-NETs candidates to endosciopic resection and the efficacy of endoscopic resection in gastrointestinal neuroendocrine NETs’ treatment. Methods: This is a retrospective analysis of a prospectively collected database. Patients with GE-NETs that underwent EUS and endoscopic resection at Istituto Oncologico Europeo (IEO) were included. Results: From September 2001 to January 2016, 21 patients for a total of 22 GE-NETs underwent EUS: 21 GE-NETs were confined to the submucosa layer; 1 case presented a doubtful involvement of the proper muscolaris layer. 11 NETs were in the stomach, 5 NETs in the duodenum and 5 NETs in the rectum. All but one rectal NET case were negative for metastatic lymph nodes. All the 22 lesions were endoscopically resected in one piece by endoscopic resection. The histological analysis confirmed that twenty-one lesions were confined to the submucosa layer and that one case was involved the proper muscolaris layer. The involvement of lymph nodes was evaluated in only the two cases who underwent surgical resection. Ten out of 22 lesions had positive margins at the histological analysis but no recurrence were observed during follow-up (mean 34 months; range 3-126). Conclusions: EUS is useful for estimating the depth of invasion of type 1 gastric neuroendocrine tumor, duodenal and rectal neuroendocrine tumors and for determining whether endoscopic resection is indicated. Endoscopic resection is effective in gastrointestinal neuroendocrine NETs’ treatment.
Laterza, Liboria <1981>. "L'Ecoendoscopia nella stadiazione locale dei tumori neuroendocrini del tratto digestivo suscettibili di resezione endoscopica: l'esperienza di un centro." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2016. http://amsdottorato.unibo.it/7390/.
Full textBackground and aim: Diagnostic role of endoscopic ultrasound (EUS) in gastrointestinal neuroendocrine tumors (GE-NETs) is the local staging based on the assessment of wall depth (T) and of lymph nodes metastasis (N). Diagnostic accuracy of EUS in T-staging is 94-100%. Endoscopic resection is a treatment option in selected cases. Aim of the current study was to evaluate diagnostic accuracy of EUS in the local staging of GE-NETs candidates to endosciopic resection and the efficacy of endoscopic resection in gastrointestinal neuroendocrine NETs’ treatment. Methods: This is a retrospective analysis of a prospectively collected database. Patients with GE-NETs that underwent EUS and endoscopic resection at Istituto Oncologico Europeo (IEO) were included. Results: From September 2001 to January 2016, 21 patients for a total of 22 GE-NETs underwent EUS: 21 GE-NETs were confined to the submucosa layer; 1 case presented a doubtful involvement of the proper muscolaris layer. 11 NETs were in the stomach, 5 NETs in the duodenum and 5 NETs in the rectum. All but one rectal NET case were negative for metastatic lymph nodes. All the 22 lesions were endoscopically resected in one piece by endoscopic resection. The histological analysis confirmed that twenty-one lesions were confined to the submucosa layer and that one case was involved the proper muscolaris layer. The involvement of lymph nodes was evaluated in only the two cases who underwent surgical resection. Ten out of 22 lesions had positive margins at the histological analysis but no recurrence were observed during follow-up (mean 34 months; range 3-126). Conclusions: EUS is useful for estimating the depth of invasion of type 1 gastric neuroendocrine tumor, duodenal and rectal neuroendocrine tumors and for determining whether endoscopic resection is indicated. Endoscopic resection is effective in gastrointestinal neuroendocrine NETs’ treatment.
Corradi, Francesco <1972>. "Ruolo dell'elastometria pulsata monodimensionale ad ultrasuoni (fibroscan) nella stadiazione della fibrosi epatica in pazienti sottoposti a trapianto ortotopico di fegato con recidiva di epatite C." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/577/1/corradi.pdf.
Full textCorradi, Francesco <1972>. "Ruolo dell'elastometria pulsata monodimensionale ad ultrasuoni (fibroscan) nella stadiazione della fibrosi epatica in pazienti sottoposti a trapianto ortotopico di fegato con recidiva di epatite C." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/577/.
Full textLanzoni, M. "IMPLEMENTAZIONE DI MODELLI PER VARIABILI RISPOSTA QUALITATIVE E MISURE PER LA VALUTAZIONE DELLA CAPACITÀ PREDITTIVA: APPLICAZIONE ALLA STADIAZIONE DELLA FIBROSI EPATICA IN PAZIENTI CON EPATITE CRONICA C." Doctoral thesis, Università degli Studi di Milano, 2014. http://hdl.handle.net/2434/232972.
Full textPultrone, Cristian Vincenzo <1982>. "Il ruolo della TC/PET con anti-3-18F-FACBC nella stadiazione dei pazienti affetti da neoplasia prostatica ad alto rischio e nella ristadiazione dei pazienti con ripresa biochimica dopo trattamento radicale." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2017. http://amsdottorato.unibo.it/8126/1/Pultrone_Cristian_tesi.pdf.
Full textPurpose: To compare the accuracy of 18F-FACBC and 11C-choline PET/CT in pre-operative staging of patients affected by prostate cancer and in patients radically treated for prostate cancer presenting with biochemical relapse. Methods: This prospective study was divided in two phases. In the “Phase I” we enrolled 100 consecutive patient radically treated for prostate cancer(PCa) and presenting with rising PSA. Of these 100 patients, 89 were included in the analysis with the following inclusion criteria: a)biochemical relapse; b)no hormonal therapy at the time of the scans. In the “Phase II” we enrolled 94 consecutive patients affected by PCa. Of these 94 patients, 80 were included in the analysis with the following inclusion criteria: a)High-risk PCa; b)no bone metastases c)no hormonal therapy. All patients underwent radical prostatectomy with lymphadenectomy. Sensitivity, specificity, PPV, NPV and accuracy were calculated for both the tracers. For phase I patients the standard of reference was follow-up at 1 year (including correlative imaging, PSA trend and pathology when available),for phase II patients was the histology. Results: In patients-based analysis sensitivity, specificity, PPV, NPV and accuracy for 11C-choline and 18F-FACBC PET/CT in restaging (phaseI) were: 32%vs37%, 40%vs67%, 90%vs97%, 3%vs4%, 32%vs38% respectively. Categorizing patients by PSA level (<1 ng/ml 28 patients, 1-2 ng/ml 28 patients, 2–3 ng/ml 11 patients, ≥3 ng/ml 22 patients) the number of patients with TP findings were generally higher with 18F-FACBC than with 11C-choline. In patients-based analysis sensitivity, specificity, PPV, NPV and accuracy for 11C-choline and 18F-FACBC PET/CT in staging (phaseII) were: 57.9%vs52.6%, 68.9%vs85.2%, 36.7%vs52.6%, 84%vs85.2%, 66.2%vs77.5% respectively. Conclusion: 18F-FACBC can be considered an alternative tracer to 11C-choline in the setting of patients with biochemical relapse after radical prostatectomy and in PCa staging. Last but not least thanks to its long half-life this radiotracer can be used also in PET Centers without cyclotron.
Pecorelli, Anna <1985>. "Cambiamenti epidemiologici dell'epatocarcinoma agli inizi del xxi secolo: Dal ruolo emergente delle malattie dismetaboliche quali fattori eziopatogemetici alla necessita' di revisione del sistema di stadiaziome." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2015. http://amsdottorato.unibo.it/7132/1/Pecorelli_Anna_Tesi.pdf.
Full textBackground and aim: the rapid spread of metabolic diseases is changing the epidemiology of hepatocellular carcinoma (HCC). Aim of the present thesis is, through four studies, to analyze the impact of these changes in the clinical management of patients with HCC. Materials and methods: four cohort studies, conducted with retrospective analysis of the ITA.LI.CA database. Study 1:3658 patients enrolled between 01-01-2001 and 31-12-2012 and divided by date of diagnosis: 2001 to 2004 (954 patients), 2005-2008 (1122 patients), 2009-2012 (1582 patients ). Study 2: comparative analysis of 756 patients with HCC-NAFLD and 611 patients with HCC-HCV. Study 3: proposal of four alternative models to original BCLC and validation of a proposed intermediate substaging, considering 2606 patients enrolled between 01-01-2000 and 31-12-2012 and reallocated according to different degrees of performance status (PS ). Study 4: analysis of 696 patients with HCC in intermediate stage diagnosed after 1999 and stratified by treatment. Results: Study 1: increasing of age at diagnosis and metabolic etiologies; more frequent onset of HCC in early stage and with more preserved liver function; increased survival after 2008. Study 2: patients with NAFLD-HCC show most frequently infiltrative tumour, diagnosed out of surveillance, with worse prognosis than patients HCC-HCV. This survival difference is eliminated by removing confounding factors through propensity analysis. Study 3: PS1 is not an independent predictor of survival. Model 4 (which considers PS0=PS1 and the proposed of substaging), has the best discriminative capacity. Studt 4: curative treatments reduce mortality more than TACE, even after propensity analysis. Conclusions: The widespread of metabolic diseases will involve an HCC diagnosis in a more advanced stage, when symptomatic, making it necessary to establish a screening program. T better stratify and manage patients, we must reconsider the role of PS and offer a range of treatment options for patients in the intermediate stage.
Pecorelli, Anna <1985>. "Cambiamenti epidemiologici dell'epatocarcinoma agli inizi del xxi secolo: Dal ruolo emergente delle malattie dismetaboliche quali fattori eziopatogemetici alla necessita' di revisione del sistema di stadiaziome." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2015. http://amsdottorato.unibo.it/7132/.
Full textBackground and aim: the rapid spread of metabolic diseases is changing the epidemiology of hepatocellular carcinoma (HCC). Aim of the present thesis is, through four studies, to analyze the impact of these changes in the clinical management of patients with HCC. Materials and methods: four cohort studies, conducted with retrospective analysis of the ITA.LI.CA database. Study 1:3658 patients enrolled between 01-01-2001 and 31-12-2012 and divided by date of diagnosis: 2001 to 2004 (954 patients), 2005-2008 (1122 patients), 2009-2012 (1582 patients ). Study 2: comparative analysis of 756 patients with HCC-NAFLD and 611 patients with HCC-HCV. Study 3: proposal of four alternative models to original BCLC and validation of a proposed intermediate substaging, considering 2606 patients enrolled between 01-01-2000 and 31-12-2012 and reallocated according to different degrees of performance status (PS ). Study 4: analysis of 696 patients with HCC in intermediate stage diagnosed after 1999 and stratified by treatment. Results: Study 1: increasing of age at diagnosis and metabolic etiologies; more frequent onset of HCC in early stage and with more preserved liver function; increased survival after 2008. Study 2: patients with NAFLD-HCC show most frequently infiltrative tumour, diagnosed out of surveillance, with worse prognosis than patients HCC-HCV. This survival difference is eliminated by removing confounding factors through propensity analysis. Study 3: PS1 is not an independent predictor of survival. Model 4 (which considers PS0=PS1 and the proposed of substaging), has the best discriminative capacity. Studt 4: curative treatments reduce mortality more than TACE, even after propensity analysis. Conclusions: The widespread of metabolic diseases will involve an HCC diagnosis in a more advanced stage, when symptomatic, making it necessary to establish a screening program. T better stratify and manage patients, we must reconsider the role of PS and offer a range of treatment options for patients in the intermediate stage.
PARRINELLO, GIAMPIERO. "Diagnostica sperimentale nella valutazione dell’infiltrazione profonda del cancro delle corde vocali." Doctoral thesis, 2016. http://hdl.handle.net/2158/1041462.
Full textBooks on the topic "Stadiazione"
Greene, Frederick L., Carolyn C. Compton, April G. Fritz, Jatin P. Shah, and David P. Winchester, eds. Atlante Per La Stadiazione Dei Tumori Maligni. Milano: Springer Milan, 2007. http://dx.doi.org/10.1007/978-88-470-0694-2.
Full textFritz, April G., Carolyn C. Compton, and Frederick L. Greene. AJCC Atlante per la stadiazione dei tumori maligni. Springer, 2008.
Find full text(Editor), Frederick L. Greene, Carolyn C. Compton (Editor), April G. Fritz (Editor), Jatin Shah (Editor), David P. Winchester (Editor), G. Gherardi (Translator), and F. Bianchi (Translator), eds. AJCC Atlante per la stadiazione dei tumori maligni. Springer, 2007.
Find full textBook chapters on the topic "Stadiazione"
Cirillo, Stefano, Massimo Petracchini, Annalisa Macera, and Daniele Regge. "Ruolo della RM nella stadiazione del carcinoma prostatico." In Imaging RM della prostata, 127–38. Milano: Springer Milan, 2010. http://dx.doi.org/10.1007/978-88-470-1516-6_16.
Full text